HC Wainwright Report, page-16

Montrachet, we must be missing something somewhere

We need to do more research

Reading Ongoing discussions centring around the actual costs of the drugs to each patient on the market

I thought that NRT was around 12 months out from commencing Phase 1 trials on one of its drugs - yet it seems like success in all 3 has been factored in and they are already on the market..

I hope people really DYOR and seek paid professional advice